?
- 首頁
- 關(guān)于我們
- 新聞中心
- 研發(fā)中心
- 產(chǎn)品介紹
抗體檢測試劑
判斷是否有供者特異性抗體(DSA)
詳情>>
- 檢測服務(wù)
- 技術(shù)支持
- 生物信息服務(wù)
摘要：Newly diagnosed patients with high-risk acute graft-versus-host disease (aGVHD) often experience poor clinical outcomes and low complete remission rates. Ruxolitinib with corticosteroids showed promising efficacy in improving response and failure free survival in our phase I study. This study (ClinicalTrials.gov: NCT04061876) sought to evaluate the safety and effectiveness of combining ruxolitinib (RUX, 5 mg/day) with...
資料分類：文獻資料
上傳時間：2025-02-25
資料下載：
摘要：This scoring system consistently classified patients into three categories of risk that predicted response to treatment within 28 days as well as risk of mortality from acute graft-versus-host disease.
資料分類：文獻資料
上傳時間：2018-02-06
資料下載：
摘要：The paper had compared 12 biomarkers in plasma obtained a median of 16 days after therapy initiation from patients with a complete response by day 28 after therapy initiation and in plasma obtained from patients with progressive GVHD during therapy. We found ST2 levels measured at the initiation of therapy for GVHD and during the first month after transplantation improved risk stratification for treatment-resistant GVHD and death without relapse after transplantation.
資料分類：文獻資料
上傳時間：2018-01-20
資料下載：
摘要：The paper had compared 8 biomarkers in plasma and found REG3α is a plasma biomarker of GI GVHD that can be combined with clinical stage and histologic grade to improve risk stratification of patients.
資料分類：文獻資料
上傳時間：2018-01-12
資料下載：
摘要：GenDx excellerator?、AlleleSEQR?、NGSgo?等系列產(chǎn)品獲得CE認證。
資料分類：產(chǎn)品證書
上傳時間：2018-01-04
資料下載：
摘要：HLA基因高分辨分型試劑（一代測序）
資料分類：使用說明
上傳時間：2017-12-26
資料下載：
摘要：HLA基因高分辨分型試劑（一代測序，原雅培HLA分型試劑）
資料分類：使用說明
上傳時間：2017-12-23
資料下載：
?
